Search for: "Janssen Research " Results 81 - 100 of 209
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Jan 2018, 5:00 am by melissalafreniere
Johnson and Johnson’s Janssen Pharmaceuticals and Bayer Health Care market Xarelto and together they shared the news of the failed phase three study in a press release last October. [read post]
29 Dec 2016, 8:26 am by Clay Hodges
Despite large amounts of time and money spent on drug and medical device research and development, those drugs and devices don’t always work as intended. [read post]
31 Mar 2012, 2:59 am
NRDC scientist Sara Janssen expressed disappointment in the agency's decision: "BPA is a toxic chemical that has no place in our food supply. [read post]
29 Mar 2015, 8:00 am by Majed Nachawati
The study, sponsored by the manufacturers of Xarelto, Bayer HealthCare and Janssen, included about 5,000 patients at risk of pulmonary embolism. [read post]
27 Feb 2014, 12:46 pm
Researchers followed the pediatric subjects beginning from their first trimester in utero for up to 15 years. [read post]
8 Sep 2014, 12:00 am by David Jensen
Last month, the firm announced it had received $20 million (see here and here) from Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson. [read post]
10 Feb 2016, 6:51 am by David Jensen
The effort is showing promising results, according to the stem cell agency.Last week, in a sign that ViaCyte has was moving along nicely,  J&J turned over its Janssen BetaLogics group to ViaCyte. [read post]
25 Mar 2014, 7:41 pm by FDABlog HPM
  Several amicus briefs were filed by interested parties, including Washington Legal Foundation and Allied Educational Foundation, Pharmaceutical Research and Manufacturers of America, Public Citizen, AARP, the Arkansas Chamber of Commerce, a former FDA Commissioner, and 34 states. [read post]
20 Feb 2018, 5:00 am by Christina Spicer
” Violations included discarding medical records, unauthorized unblinding, and even falsification of research records, according to the complaint. [read post]
10 Nov 2015, 11:33 am by Tom Lamb
The differing research results for Eliquis and Xarelto mentioned in the final two paragraphs, above, mean that Eliquis may or may not cause fewer dangerous major bleeding events than Xarelto. [read post]
11 Jan 2018, 5:00 am by melissalafreniere
Janssen Research & Development LLC, et al., Case No. 2:17-cv-17468, in the U.S. [read post]
26 Jun 2013, 6:43 am
  Finding the patent bad in both respects, the Judge stated: The upshot is that the Patent does no more than invite the skilled team to perform what Prof Wisniewski rightly described as a “very significant research project with a high prospect of failure” and, if they succeed, claims the fruits of their research. [read post]
7 Jan 2013, 3:03 am by Andrew Lavoott Bluestone
The Supreme Court also properly denied the plaintiffs' requests for leave to replead that are raised on this appeal (see generally Janssen v Incorporated Vil. of Rockville Ctr., 59 AD3d 15, 27; Smith-Hoy v AMC Prop. [read post]
13 Feb 2015, 12:01 pm by Majed Nachawati
The FDA approved Xarelto as treatment for each concern after some research and time. [read post]
3 Feb 2014, 4:05 am by Howard Friedman
Janssen, Led Blindly: One Circuit's Struggle to Faithfully Apply the U.S. [read post]
21 Jul 2014, 10:55 am by Majed Nachawati
However, a study released in 2006 by Duke researchers showed that children who took Risperdal had higher prolactin levels. [read post]
17 Jan 2018, 5:00 am by melissalafreniere
Janssen Research and Developments LLC, et al., Case No. 2:17-cv-17526, in the U.S. [read post]